Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: ACS Chem Neurosci. 2018 May 2;9(7):1840–1848. doi: 10.1021/acschemneuro.8b00139

Table 4.

Antinociceptive Activity of Compounds 7a–r in Mouse WWTW Assaya

C-8 substitution antinociceptive activity at 10 mg/kg duration of action C-8 substitution antinociceptive activity at 10 mg/kg duration of action
7a benzyl no activity 7j methylmorpholine no activity
7b methyl fully efficacious 1.5 h 7k methylpiperazine did not test
7c ethyl fully efficacious 1.0 h 7l phenethyl no activity
7d n-propyl no activity 7m ethyl amide no activity
7e n-butyl fully efficacious 2.5 h 7n ethyl ester fully efficacious 2.5 h
7f t-butyl partially active 7o phenyl amide did not test
7g fluoro no activity 7p benzyl amide no activity
7h trifluoromethyl no activity 7q bromo no activity
7i methylpiperidine no activity 7r carboxylic acid no activity
a

Results from the mouse WWTW assay after ip administration of compound 7a–r at 10 mg/kg. Antinociceptive activities defined as fully efficacious for 20 s latency to tail withdrawal, partially active for 10 s above baseline, or no activity for no significant difference from baseline. Duration of action is defined here as the time it takes to return to baseline after a 10 mg/kg bolus injection of test compound.